OBJECTIVE: The purpose of this study was to investigate whether the effects of 17beta-estradiol tablets that are designed for the treatment of postmenopausal urovaginal atrophy are influenced by the site of placement into the vagina. STUDY DESIGN: In this controlled crossover trial, 10 postmenopausal women received a single 17beta-estradiol tablet in the outer or inner one third of the vagina. Before and 3 hours after treatment, the pulsatility index, resistance index, and blood flow were evaluated in the uterine and periurethral vessels by Doppler examination. Parallel 17beta-estradiol serum evaluations were performed. RESULTS: Comparable and significant increases in 17beta-estradiol were observed. After inner administration, the pulsatility index and resistance index of both uterine arteries decreased; uterine artery blood flow increased significantly (P <.0001) but decreased in periurethral vessels (P <.02). After outer administration, the uterine artery pulsatility index, resistance index, and blood flow did not change, and the periurethral blood flow significantly increased (P <.0001). CONCLUSION: For optimizing the efficacy while minimizing the risk of endometrial hyperplasia, 17beta-estradiol tablets must be placed in the outer one third of the vagina.
RCT Entities:
OBJECTIVE: The purpose of this study was to investigate whether the effects of 17beta-estradiol tablets that are designed for the treatment of postmenopausal urovaginal atrophy are influenced by the site of placement into the vagina. STUDY DESIGN: In this controlled crossover trial, 10 postmenopausal women received a single 17beta-estradiol tablet in the outer or inner one third of the vagina. Before and 3 hours after treatment, the pulsatility index, resistance index, and blood flow were evaluated in the uterine and periurethral vessels by Doppler examination. Parallel 17beta-estradiol serum evaluations were performed. RESULTS: Comparable and significant increases in 17beta-estradiol were observed. After inner administration, the pulsatility index and resistance index of both uterine arteries decreased; uterine artery blood flow increased significantly (P <.0001) but decreased in periurethral vessels (P <.02). After outer administration, the uterine artery pulsatility index, resistance index, and blood flow did not change, and the periurethral blood flow significantly increased (P <.0001). CONCLUSION: For optimizing the efficacy while minimizing the risk of endometrial hyperplasia, 17beta-estradiol tablets must be placed in the outer one third of the vagina.
Authors: Ruben J Kuon; Shao-Qing Shi; Holger Maul; Christof Sohn; James Balducci; William L Maner; Robert E Garfield Journal: Am J Obstet Gynecol Date: 2010-05 Impact factor: 8.661
Authors: Richard J Santen; D Craig Allred; Stacy P Ardoin; David F Archer; Norman Boyd; Glenn D Braunstein; Henry G Burger; Graham A Colditz; Susan R Davis; Marco Gambacciani; Barbara A Gower; Victor W Henderson; Wael N Jarjour; Richard H Karas; Michael Kleerekoper; Roger A Lobo; JoAnn E Manson; Jo Marsden; Kathryn A Martin; Lisa Martin; JoAnn V Pinkerton; David R Rubinow; Helena Teede; Diane M Thiboutot; Wulf H Utian Journal: J Clin Endocrinol Metab Date: 2010-06-21 Impact factor: 5.958
Authors: Sheryl A Kingsberg; Lisa Larkin; Michael Krychman; Sharon J Parish; Brian Bernick; Sebastian Mirkin Journal: Menopause Date: 2019-02 Impact factor: 2.953
Authors: Ginger D Constantine; Shelli Graham; Kate Lapane; Kathleen Ohleth; Brian Bernick; James Liu; Sebastian Mirkin Journal: Menopause Date: 2019-07 Impact factor: 2.953
Authors: Ashley F George; Karen S Jang; Mette Nyegaard; Jason Neidleman; Trimble L Spitzer; Guorui Xie; Joseph C Chen; Eytan Herzig; Anders Laustsen; Erika G Marques de Menezes; Sahar Houshdaran; Christopher D Pilcher; Philip J Norris; Martin R Jakobsen; Warner C Greene; Linda C Giudice; Nadia R Roan Journal: Hum Reprod Date: 2020-03-27 Impact factor: 6.918
Authors: Yongmei Huang; Ruth B Merkatz; Sharon L Hillier; Kevin Roberts; Diana L Blithe; Régine Sitruk-Ware; Mitchell D Creinin Journal: PLoS One Date: 2015-08-12 Impact factor: 3.240